CPJ reports 26% decrease in nine-month net profit attributable to shareholders

November 20, 2025

Caribbean Producers Jamaica Limited (CPJ)
Unaudited financials for the nine months ended September 30, 2025

Caribbean Producers Jamaica Limited (CPJ) for the nine months ended September 30, 2025, reported a 33% increase in Gross Operating Revenue, totaling US$146.50 million compared to US$109.93 million in the corresponding period last year. Gross Operating Revenue for the third quarter increased by 71% to US$58.14 million, compared to US$34.01 million for the comparable quarter of 2024.

Cost of Operating Revenue amounted to US$105.53 million (2024: US$80.38 million), representing a 31% increase year over year. Consequently, gross profit increased by 39% to US$40.97 million, compared to US$29.55 million for the nine months ended September 30, 2024. The company booked gross profit of US$16.80 million for the third quarter versus US$10.15 million reported for the similar quarter of 2024.

Selling and Administrative Expenses increased by 49% to US$29.99 million (2024: US$20.19 million). As a result, Other Operating Income for the nine months ended September 30, 2025, amounted to US$91,563, an 85% decrease relative to the US$600,264 reported in 2024.

Operating Profit for the nine months ended September 30, 2025, amounted to US$6.54 million, a 14% increase relative to US$5.76 million reported in 2024. Operating Profit for the third quarter amounted to US$316,290 (2024: US$839,496).

Finance Income totalled US$476, a 98% decrease from the corresponding period last year (2024: US$24,640), while Finance Cost totalled US$3.29 million, a 44% increase from the corresponding period last year (2024: US$2.29 million).

Profit Before Taxation for the nine months ended September 30, 2025, amounted to US$3.25 million, a 7% decrease relative to US$3.50 million reported in 2024. Loss Before Taxation for the third quarter amounted to US$1.19 million (2024: loss before taxation of US$27,733).

The taxation charge for the nine months ended September 30, 2025, increased by 82% to US$1.00 million (2024: US$549,267). Net Profit for the nine months amounted to US$2.25 million, a 24% decrease from the US$2.95 million reported in 2024. For the third quarter, Net Loss was US$1.04 million (2024: net loss of US$80,737).

Consequently, Earnings Per Share for the nine months amounted to US$0.0023 / J$0.37 (2024: US$0.0031 / J$0.49), while Loss Per Share for the quarter totalled US$0.0007 / J$0.11 (2024: US$0.00003 / J$0.0048). The twelve-month trailing EPS was US$0.0052/J$0.84, and the number of shares used in these calculations was 1,100,000,000.

Notably, CPJ’s stock price closed the trading period on November 19, 2025, at J$7.37, with a corresponding P/E ratio of 8.73x.

Balance Sheet Highlights

The company’s assets totalled US$114.88 million (2024: US$92.89 million). This increase was attributable to Accounts Receivable, which amounted to US$32.70 million (2024: US$15.26 million).

Shareholders’ equity was US$40.75 million (2024: US$35.59 million), representing a book value per share of US$0.37 / J$59.64 (2024: US$0.32 / J$51.36).

 

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

 

2025-11-20T09:33:49-05:00